EUVIMEDEUVIMED entdecken
Crossref

Reprogramming Enfumafungin Biosynthesis for High-Titer Production in the Endophytic Fungus Hormonema carpetanum ATCC 74360

Jing Wo iD, Haipeng Yu, Yige Yang, Hongxi Wu, Fangjie Xiong, Dekun Kong iD

ACS Synthetic Biology · 2026

DOI: 10.1021/acssynbio.6c00248 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Synthetic Biology, 2026. Verfasst von Jing Wo und 5 weiteren Autor:innen. Beteiligte Einrichtung: Collaborative Innovation Center of Yangtze River Delta Region Green Pharmaceuticals, College of Pharmaceutical Sciences, Zhejiang University of Techn…. Hauptthemen laut MEDLINE: Metabolic Engineering, Ascomycota. Die Arbeit nennt 49 Literaturangaben. Gefördert von: National Natural Science Foundation of China, National Key Research and Development Program of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Enfumafungin is the essential precursor for the FDA-approved antifungal agent Ibrexafungerp, yet its production is hindered by low yields, restrictive solid-state fermentation, and the genetic intractability of its producer strain, Hormonema carpetanum ATCC 74360. Here, we developed a CRISPR/Cas9-mediated platform that halved the genetic iteration cycle to less than 15 days. By rewiring the biosynthetic cluster through promoter engineering, we successfully transitioned production to scalable liquid fermentation, achieving an initial 21.6 mg/L. Then, the mevalonate pathway genes (tHMGR, ERG9, and ERG1) were overexpressed, which successfully boosted the titer to 250.1 mg/L. Following medium optimization, the engineered strain HC07 reached a record-breaking 592.4 mg/L in 250 mL shake flasks, the highest yield achieved via metabolic engineering to date. This study provides a robust microbial platform and a streamlined genetic toolbox, paving the way for the sustainable biomanufacturing of next-generation triterpenoid antifungals.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Metabolic EngineeringAscomycotaCRISPR-Cas SystemsFermentationPromoter Regions, GeneticMevalonic AcidAntifungal Agents

Stichwörter der Autor:innen

Hormonema carpetanumCRISPR/cas9enfumafunginmetabolic engineeringpromoter engineeringtriterpenoids

Substanzen

Mevalonic AcidAntifungal Agents

Autor:innen und Institutionen

  • Collaborative Innovation Center of Yangtze River Delta Region Green Pharmaceuticals, College of Pharmaceutical Sciences, Zhejiang University of Technology, Hangzhou310014, China.
  • Chongqing Zhihe Biopharmaceutical Co., Ltd., Chongqing400715, China.
  • College of Pharmaceutical Sciences, Southwest University, Chongqing400715, China.
  • College of Agronomy and Biotechnology, Southwest University, Chongqing400715, China.

ORCID-Profile: Jing Wo, Dekun Kong

Förderung

  • National Natural Science Foundation of China
  • National Key Research and Development Program of China

Zitieren

APA

Wo, J., Yu, H., Yang, Y., Wu, H., Xiong, F., & Kong, D. (2026). Reprogramming Enfumafungin Biosynthesis for High-Titer Production in the Endophytic Fungus Hormonema carpetanum ATCC 74360. ACS Synthetic Biology. https://doi.org/10.1021/acssynbio.6c00248

Vancouver

Wo J, Yu H, Yang Y, Wu H, Xiong F, Kong D. Reprogramming Enfumafungin Biosynthesis for High-Titer Production in the Endophytic Fungus Hormonema carpetanum ATCC 74360. ACS Synthetic Biology. 2026. doi:10.1021/acssynbio.6c00248

BibTeX
@article{Wo2026,
  author = {Wo, Jing and Yu, Haipeng and Yang, Yige and Wu, Hongxi and Xiong, Fangjie and Kong, Dekun},
  title = {Reprogramming Enfumafungin Biosynthesis for High-Titer Production in the Endophytic Fungus Hormonema carpetanum ATCC 74360},
  journal = {ACS Synthetic Biology},
  year = {2026},
  doi = {10.1021/acssynbio.6c00248}
}
Kostenlos starten →